Literature DB >> 12658538

Chronic rejection of small bowel grafts: pediatric and adult study of risk factors and morphologic progression.

Maria Parizhskaya1, Clara Redondo, Anthony Demetris, Ronald Jaffe, Jorge Reyes, Kris Ruppert, Lillian Martin, Kareem Abu-Elmagd.   

Abstract

One hundred and seventy-two patients underwent small bowel transplantation at Children's Hospital of Pittsburgh and University of Pittsburgh Medical Center between May 1990 and August 2001. Thirty-four patients had complete or partial resection of their primary graft and in 15, histologic features of chronic rejection were present in the resected small bowel. This is a descriptive and correlative study of the demographic, perioperative, and histologic features associated with progression to intestinal graft failure. Variable features associated with an increased risk of chronic rejection included acute rejection within the 1st month, increased number and higher grade of acute rejection episodes, isolated small bowel grafts rather than small bowel-liver grafts, older recipient age, non-Caucasian race, and Caucasian to non-Caucasian transplant. The mucosal biopsies showed predictive changes many months before the grafts were excised. The mucosal biopsy diagnosis of chronic vascular rejection can be difficult because the affected vessels, the distal branches of the mesenteric arteries, and the larger arteries of the subserosa and submucosa are not routinely sampled. The possibility of underlying arteriopathy, however, can be inferred in some instances from the presence of secondary mucosal changes in the small bowel biopsies though the "early" changes lack specificity. It is the progression of biopsy findings over time that is predictive of outcome. It is important to recognize the persistence of "late" mucosal changes of chronic rejection so that patients are not subjected to increased immune suppression when it is unlikely to be of significant benefit.

Entities:  

Mesh:

Year:  2003        PMID: 12658538     DOI: 10.1007/s10024-002-0039-4

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  6 in total

1.  Sequential observations show upregulation of TGF-beta1 at the early phase of chronic small bowel rejection in rats.

Authors:  Haiyun Zhang; Yousheng Li; Jian Wang; Bin Lu; Bin Wang; Qiurong Li; Jieshou Li
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

2.  Modified "liver-sparing" multivisceral transplant with preserved native spleen, pancreas, and duodenum: technique and long-term outcome.

Authors:  Ruy J Cruz; Guilherme Costa; Geoffrey Bond; Kyle Soltys; William C Stein; Guosheng Wu; Lillian Martin; Darlene Koritsky; John McMichael; Rakesh Sindhi; George Mazariegos; Kareem M Abu-Elmagd
Journal:  J Gastrointest Surg       Date:  2010-09-17       Impact factor: 3.452

Review 3.  Intestinal transplantation in children: a review of immunotherapy regimens.

Authors:  Navdeep S Nayyar; William McGhee; Dolly Martin; Rakesh Sindhi; Kyle Soltys; Geoffrey Bond; George V Mazariegos
Journal:  Paediatr Drugs       Date:  2011-06-01       Impact factor: 3.022

4.  Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling.

Authors:  Parvaneh Rafiee; Jan Heidemann; Hitoshi Ogawa; Nathan A Johnson; Pamela J Fisher; Mona S Li; Mary F Otterson; Christopher P Johnson; David G Binion
Journal:  Cell Commun Signal       Date:  2004-06-02       Impact factor: 5.712

5.  Liver-inclusive intestinal transplantation results in decreased alloimmune-mediated rejection but increased infection.

Authors:  Guosheng Wu; Ruy J Cruz
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-12-28

Review 6.  Intestinal transplantation in children: current status.

Authors:  Andrea Martinez Rivera; Paul W Wales
Journal:  Pediatr Surg Int       Date:  2016-03-31       Impact factor: 1.827

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.